SOX2 expression in prostate cancer drives resistance to nuclear hormone receptor signaling inhibition through the WEE1/CDK1 signaling axis.

Cancer Lett · 2023 · PMC13037384 · PMID 37169162

Europe PMC DOI

hedged sentence

0.3108

closest p · 6.2× alpha

0.3108

boldest claim

The sentences

did not reach statistical significancep = 0.3108not close (p > 0.1)

CDKN2A and E2F1 expression was also upregulated in the SOX2 HI quartile relative to SOX2 LOW (not shown, p < 0.0001), while expression differences between SOX2 HI and LOW quartiles for TGFB1 and CDKN1C did not reach statistical significance (not shown, p = 0.3108 and p = 0.1723, respectively).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.